chr7-24291686-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The NM_000905.4(NPY):c.293G>A(p.Ter98=) variant causes a stop retained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000396 in 1,614,142 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00032 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00040 ( 6 hom. )
Consequence
NPY
NM_000905.4 stop_retained
NM_000905.4 stop_retained
Scores
2
Clinical Significance
Conservation
PhyloP100: 7.69
Genes affected
NPY (HGNC:7955): (neuropeptide Y) This gene encodes a neuropeptide that is widely expressed in the central nervous system and influences many physiological processes, including cortical excitability, stress response, food intake, circadian rhythms, and cardiovascular function. The neuropeptide functions through G protein-coupled receptors to inhibit adenylyl cyclase, activate mitogen-activated protein kinase (MAPK), regulate intracellular calcium levels, and activate potassium channels. A polymorphism in this gene resulting in a change of leucine 7 to proline in the signal peptide is associated with elevated cholesterol levels, higher alcohol consumption, and may be a risk factor for various metabolic and cardiovascular diseases. The protein also exhibits antimicrobial activity against bacteria and fungi. [provided by RefSeq, Oct 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 7-24291686-G-A is Benign according to our data. Variant chr7-24291686-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2074605.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 49 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NPY | NM_000905.4 | c.293G>A | p.Ter98= | stop_retained_variant | 4/4 | ENST00000242152.7 | |
LOC107986777 | XR_001745132.2 | n.209+27671C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NPY | ENST00000242152.7 | c.293G>A | p.Ter98= | stop_retained_variant | 4/4 | 1 | NM_000905.4 | P1 | |
NPY | ENST00000405982.1 | c.293G>A | p.Ter98= | stop_retained_variant | 3/3 | 1 | P1 | ||
NPY | ENST00000407573.5 | c.293G>A | p.Ter98= | stop_retained_variant | 5/5 | 3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000322 AC: 49AN: 152196Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
49
AN:
152196
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000748 AC: 188AN: 251414Hom.: 1 AF XY: 0.000972 AC XY: 132AN XY: 135872
GnomAD3 exomes
AF:
AC:
188
AN:
251414
Hom.:
AF XY:
AC XY:
132
AN XY:
135872
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000404 AC: 590AN: 1461828Hom.: 6 Cov.: 30 AF XY: 0.000523 AC XY: 380AN XY: 727220
GnomAD4 exome
AF:
AC:
590
AN:
1461828
Hom.:
Cov.:
30
AF XY:
AC XY:
380
AN XY:
727220
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000322 AC: 49AN: 152314Hom.: 0 Cov.: 32 AF XY: 0.000416 AC XY: 31AN XY: 74486
GnomAD4 genome
AF:
AC:
49
AN:
152314
Hom.:
Cov.:
32
AF XY:
AC XY:
31
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
13
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 11, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at